What does BIROMED do?

BIROMED is a specialist medical practice in Leuven. Private Limited, started on 25 January 2019, 1 establishment.

What is the address of BIROMED?

The registered office of BIROMED is located at Karel van Lotharingenstraat 10, 3000 Leuven.

Is BIROMED still active?

Yes. According to the CBE (2 October 2026) BIROMED is active, legal situation “Normale toestand”, started on 25 January 2019.

Is BIROMED registered on Peppol?

Yes, BIROMED is registered on the Peppol network with ID 0208:0719413663.

What is the enterprise number of BIROMED?

The enterprise number of BIROMED is BE0719413663.

When was BIROMED founded?

BIROMED was founded on 25 January 2019.

Who are the directors of BIROMED?

According to the 2024 annual accounts, the directors of BIROMED are: Birgit Renard, Robert De Loecker.

Is BIROMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 January 2019; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did BIROMED make in 2024?

BIROMED posted a profit after taxes of € 432,313 in financial year 2024.

What is the revenue of BIROMED?

As a small company, BIROMED is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 673,096.

BIROMED (Private Limited) - Leuven - BE0719413663

Dossier BIROMED, printed on 2 October 2026 from databakkes.be/en/0719413663/biromed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

BIROMED from Leuven, company number BE0719413663, closed financial year 2024 with a result of € 432,313 after tax. For that financial year BIROMED recorded a gross margin of € 673,096 and equity of € 2.3 million. Compared with financial year 2023, the result moved from € 377,658 to € 432,313. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 18, 2025.

What it is worth Growing

€ 2.3 million

▲ 23% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 432,313

▲ 14% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 770,403

▲ 46% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 2.3 million.

People and assets in 2024

Vehicles and equipment

€ 5,352

▼ 78% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 11,711

▲ € 9,130 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 6,762

▲ 105% vs 2023

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 704,342 Gross margin 2021: € 704,342 First fiscal year in the series	€ 611,949 Gross margin 2022: € 611,949 ▼ 13% vs 2021 (€ 704,342) Unfavourable step	€ 611,358 Gross margin 2023: € 611,358 Unchanged (€ 611,949) Unfavourable step	€ 673,096 Gross margin 2024: € 673,096 ▲ 10% vs 2023 (€ 611,358) Favourable step	▲ 10%
Profit after taxes	€ 446,886 Profit after taxes 2021: € 446,886 First fiscal year in the series	€ 376,550 Profit after taxes 2022: € 376,550 ▼ 16% vs 2021 (€ 446,886) Unfavourable step	€ 377,658 Profit after taxes 2023: € 377,658 Unchanged (€ 376,550) Favourable step	€ 432,313 Profit after taxes 2024: € 432,313 ▲ 14% vs 2023 (€ 377,658) Favourable step	▲ 14%
Equity	€ 1,113,399 Equity 2021: € 1,113,399 First fiscal year in the series	€ 1,489,948 Equity 2022: € 1,489,948 ▲ 34% vs 2021 (€ 1,113,399) Favourable step	€ 1,867,606 Equity 2023: € 1,867,606 ▲ 25% vs 2022 (€ 1,489,948) Favourable step	€ 2,299,920 Equity 2024: € 2,299,920 ▲ 23% vs 2023 (€ 1,867,606) Favourable step	▲ 23%
Total debts	€ 119,247 Total debts 2021: € 119,247 First fiscal year in the series	€ 55,445 Total debts 2022: € 55,445 ▼ 54% vs 2021 (€ 119,247) Favourable step	€ 5,925 Total debts 2023: € 5,925 ▼ 89% vs 2022 (€ 55,445) Favourable step	€ 18,837 Total debts 2024: € 18,837 ▲ 218% vs 2023 (€ 5,925) Unfavourable step	▲ 218%
Cash	€ 709,622 Cash 2021: € 709,622 First fiscal year in the series	€ 432,588 Cash 2022: € 432,588 ▼ 39% vs 2021 (€ 709,622) Unfavourable step	€ 528,711 Cash 2023: € 528,711 ▲ 22% vs 2022 (€ 432,588) Favourable step	€ 770,403 Cash 2024: € 770,403 ▲ 46% vs 2023 (€ 528,711) Favourable step	▲ 46%
Retained profit	€ 1,094,849 Retained profit 2021: € 1,094,849 First fiscal year in the series	€ 1,471,398 Retained profit 2022: € 1,471,398 ▲ 34% vs 2021 (€ 1,094,849) Favourable step	€ 1,849,056 Retained profit 2023: € 1,849,056 ▲ 26% vs 2022 (€ 1,471,398) Favourable step	€ 2,281,370 Retained profit 2024: € 2,281,370 ▲ 23% vs 2023 (€ 1,849,056) Favourable step	▲ 23%
Balance sheet total	€ 1,268,347 Balance sheet total 2021: € 1,268,347 First fiscal year in the series	€ 1,581,258 Balance sheet total 2022: € 1,581,258 ▲ 25% vs 2021 (€ 1,268,347) Unchanged	€ 1,922,730 Balance sheet total 2023: € 1,922,730 ▲ 22% vs 2022 (€ 1,581,258) Unchanged	€ 2,364,135 Balance sheet total 2024: € 2,364,135 ▲ 23% vs 2023 (€ 1,922,730) Unchanged	▲ 23%

Key figures of BIROMED, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to BIROMED?

What happened at BIROMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Nov 18, 2025 New annual accounts for financial year 2024: profit of € 432,313 (▲ 14% vs 2023). filed late Source: NBB ↗
Jan 25, 2019 New establishment in Leuven. KBO
2019 Birgit Renard became a director. NBB
2019 Robert De Loecker became a director. NBB
Jan 25, 2019 Start of the company according to the CBE. KBO

In short

From € 446,886 profit in 2021 to € 432,313 profit in 2024.

Paid € 739,974 in corporate taxes since 2021.

Best year ever: 2021, with € 446,886 profit.

Original PDFs at the National Bank ↗

A new publication or filing at BIROMED? We notify you, reason included.

Follow BIROMED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit